Idiopathic myelofibrosis is usually a disease of adults, characterized by anaemia and splenomegaly, with a variety of changes in the blood, a slow course, and an irregular increase of fibrosis in the bone marrow (Wintrobe, 1967) . This disease may also have an acute termination; however, there is also a type of myelofibrosis which is acute from the outset, without splenomegaly or glandular enlargement, but is rapidly progressive (Lewis and Szur, 1963) . The blood shows pancytopenia. The marrow is difficult to aspirate and hypocellular. Trephine biopsy shows increased collagen and reticulin, with primitive reticulum cells and megakaryocytes. Myelofibrosis may also be secondary to polycythaemia vera, or coexist with tuberculosis, malignant disease, and leukaemia.
In childhood, cases of idiopathic myelofibrosis are rare. Secondary myelofibrosis is not uncommon in acute leukaemia, of children as well as of adults, and occurs in both lymphoblastic and granulocytic types (Kundel et al., 1964) . In 1969, Tobin, Tan, and Klimova, Indosova, and Zacharova, 1970; Holden et al., 1971) . 2 of the reported cases of idiopathic childhood myelofibrosis have also had Down's syndrome (Rosenberg and Taylor, 1958; Hillman and Forrester, 1968) . 2 more had different chromosome abnormalities affecting a clone of cells: group C monosomy (Holden et al., 1971 ) and a Philadelphia chromosome (Maas and Ruhrmann, 1971) . Adult myelofibrosis has also been reported in families, affecting father and daughter twice (Decastello, 1954; Bernard et al., 1967) and 2 brothers (Patakfalvi, Csete and Horvath, 1969) Myelofibrosis is usually included among the myeloproliferative disorders originally described by Dameshek (1951) . They have been described in children, but are rare. A number of myeloproliferative conditions have been reported in neonates with Down's syndrome, for example, neonatal erythrocytosis (Weinberger and Oleinick, 1970) , leukaemoid reaction with polycythaemia (Miller, Sherrill, Hathaway, 1967; Pochedly and Ente, 1968) or with megakaryocyte proliferation (Fujinami et al., 1961) . Better known is the syndrome of ineffective granulopoiesis masquerading as acute leukaemia (Ross, Maloney, and Desforges, 1963) . A wide variety of changes has been described in the blood of these patients, many of which, including increased activity of certain leucocyte and red cell enzymes, are probably secondary to increased cell turnover, while other changes, including changes in immunoglobulins, are probably secondary to increased infections (Woodford and Beam., 1970) .
The abnormal response of their lymphocytes to phytohaemagglutinin (Hayakawa et al., 1968; Mellmann, Younkin, and Baker, 1970) or in mixed lymphocyte culture (Sasaki and Obara, 1969) may explain, at least in part, this increased susceptibility to infection. The association of Down's syndrome and leukaemia is well known (Krivit and Good, 1957 of leukaemia. If the incidence of this combination of disorders were general, clearly far more cases would be known. This is not the case. Either our experience is exceptional or the condition is under-reported and presumably underdiagnosed, because histological examination of the bone marrow is not done. Trephine biopsy enabled a diagnosis to be made in both the cases in which it was done; and the diagnosis was confirmed after death.
The clinical and pathological syndrome of childhood myelofibrosis has varied. The first case of Rosenberg and Taylor (1958) had Down's syndrome and showed pleomorphic and bizarre cellular infiltration with haemosiderosis in the spleen, as did one of the cases described here (Case 2). The patient of Hillman and Forrester (1968) developed thrombocytosis before death, and a raised platelet count was found in the cases of Fujinami et al. (1961) and Nagai et al. (1969) . Though the case described by Klimova et al. (1970) survived 14 years, all the children with myelofibrosis and Down's syndrome have died with a rapidly progressive illness. Unlike the children with Down's syndrome and a leukaemia-like illness first described by Ross et al. (1963) , there has been no recovery.
It should not be assumed that the blast cells in the blood of these children must be leukaemic myeloblasts or lymphoblasts. Chervenick (1972) 
